CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MKKGY

Mirdametinib

Phase 2
Merck KGaA (MKKGY)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q4 '27
MKKGYPhase 2

Mirdametinib Phase 2 Est. Readout

Mirdametinib
Q4 2027~Q
CT.gov
00%
Competitive Landscape

0 competitors in NF1

View Full Landscape
Drug Information

Target Indication

NF1

Clinical Trial

NCT06159166

Last updated: 8/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.